The Wu-Tang Clan has been trying to peddle their double album Once Upon A Time In Shaolin to the highest bidder for the better part of 2015. RZA confirmed that the album sold for somewhere “in the millions” back in November, and now we know exactly who got their hands on this controversial collectors item – and our predictions were way off.
Martin Shkreli, the CEO of Turing Pharmaceuticals and apparent avid hip-hop collector, reportedly copped Shaolin for a reported cool $2 million, according to Bloomberg Businessweek. You might remember Shkreli as the surly douchebag who raised the prices on AIDS/cancer drug Daraprim from $13.50 to $750 a pill. “I could be convinced to listen to it earlier if Taylor Swift wants to hear it or something like that,” Shkreli told Bloomberg. “But for now, I think I’m going to kind of save it for a rainy day.”
In an emailed statement, RZA put in his figurative two cents: “The sale of Once Upon a Time in Shaolin was agreed upon in May, well before Martin Skhreli’s [sic] business practices came to light. We decided to give a significant portion of the proceeds to charity.”